Sherif Farag

  • 4139 Citations
  • 32 h-Index
1977 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Publications

1992

Delay by internists in obtaining diagnostic biopsies in patients with suspected cancer

Farag, S. S., Green, M. D., Morstyn, G., Sheridan, W. P. & Fox, R. M., Jan 1 1992, In : Annals of internal medicine. 116, 6, p. 473-478 6 p.

Research output: Contribution to journalArticle

16 Scopus citations

Fatal disseminated Scedosporium inflatum infection in a neutropenic immunocompromised patient

Farag, S. S., Firkin, F. C., Andrew, J. H., Soon Lee, C. & Ellis, D. H., Sep 1992, In : Journal of Infection. 25, 2, p. 201-202,IN7-IN8,203-204

Research output: Contribution to journalArticle

24 Scopus citations

Novel translocation (2;4) with consistent involvement of 2p23 in acute nonlymphocytic leukemia (M2)

Farag, S., Challis, J., White, J. & Garson, O. M., Jan 1992, In : Cancer Genetics and Cytogenetics. 58, 1, p. 48-51 4 p.

Research output: Contribution to journalArticle

9 Scopus citations
1993

Differential action of diffusible molecules in long‐term marrow culture on proliferation of leukaemic and normal haemopoietic cells

Firkin, F. C., Birner, R. & Farag, S., May 1993, In : British journal of haematology. 84, 1, p. 8-15 8 p.

Research output: Contribution to journalArticle

12 Scopus citations
1994
2 Scopus citations
1997

Lack of in vitro cross-reactivity predicts safety of low-molecular weight heparins in heparin-induced thrombocytopenia

Farag, S. S., Savoia, H., O'Malley, C. J. & McGrath, K. M., Jan 1997, In : Clinical and Applied Thrombosis/Hemostasis. 3, 1, p. 58-62 5 p.

Research output: Contribution to journalArticle

4 Scopus citations
2000

Autologous and allogeneic hematopoietic stem cell transplantation (HCT) in multiple myeloma (MM): a single institution experience

Farag, S. S., Hike, S., Elder, P. J., Marcucci, G., Penza, S. L., Mrozek, E., Avalos, B. R. & Copelan, E. A., Dec 1 2000, In : Blood. 96, 11 PART II, p. 354b

Research output: Contribution to journalArticle

2002

Chronic lymphocytic leukemia.

Kay, N. E., Hamblin, T. J., Jelinek, D. F., Dewald, G. W., Byrd, J. C., Farag, S., Lucas, M. & Lin, T., 2002, In : Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program. p. 193-213 21 p.

Research output: Contribution to journalReview article

74 Scopus citations

Erratum: (Clinical Cancer Research (September 2002) (2812-2819))

Farag, S. S., Nov 1 2002, In : Clinical Cancer Research. 8, 11, 1 p.

Research output: Contribution to journalComment/debate

Isolated trisomy of chromosomes 8, 11, 13 and 21 is an adverse prognostic factor in adults with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B 8461.

Farag, S. S., Archer, K. J., Mrózek, K., Vardiman, J. W., Carroll, A. J., Pettenati, M. J., Moore, J. O., Kolitz, J. E., Mayer, R. J., Stone, R. M., Larson, R. A. & Bloomfield, C. D., Nov 2002, In : International journal of oncology. 21, 5, p. 1041-1051 11 p.

Research output: Contribution to journalArticle

38 Scopus citations

Leukocytoreduction for acute leukemia

Porcu, P., Farag, S., Marcucci, G., Cataland, S. R., Kennedy, M. S. & Bissell, M., Mar 23 2002, In : Therapeutic Apheresis. 6, 1, p. 15-23 9 p.

Research output: Contribution to journalArticle

109 Scopus citations

Natural killer cell receptors: New biology and insights into the graft-versus-leukemia effect

Farag, S. S., Fehniger, T. A., Ruggeri, L., Velardi, A. & Caligiuri, M. A., Sep 15 2002, In : Blood. 100, 6, p. 1935-1947 13 p.

Research output: Contribution to journalReview article

398 Scopus citations

Natural killer cells: Biology and application in stem-cell transplantation

Farag, S. S., Fehniger, T., Ruggeri, L., Velardi, A. & Caligiuri, M. A., Jan 1 2002, In : Cytotherapy. 4, 5, p. 445-446 2 p.

Research output: Contribution to journalArticle

18 Scopus citations

Postremission therapy with low-dose interleukin 2 with or without intermediate pulse dose interleukin 2 therapy is well tolerated in elderly patients with acute myeloid leukemia: Cancer and Leukemia Group B study 9420

Farag, S. S., George, S. L., Lee, E. J., Baer, M., Dodge, R. K., Becknell, B., Fehniger, T., Silverman, L. R., Crawford, J., Bloomfield, C. D., Larson, R. A., Schiffer, C. A. & Caligiuri, M. A., Sep 2002, In : Clinical Cancer Research. 8, 9, p. 2812-2819 8 p.

Research output: Contribution to journalArticle

38 Scopus citations

Therapeutic applications of immunomagnetic cell selection: A review

Farag, S. S., May 1 2002, In : European Cells and Materials. 3, SUPPL. 2, p. 37-40 4 p.

Research output: Contribution to journalArticle

3 Scopus citations
2003

Biology and clinical impact of human natural killer cells

Farag, S. S., VanDeusen, J. B., Fehniger, T. A. & Caligiuri, M. A., Jul 2003, In : International Journal of Hematology. 78, 1, p. 7-17 11 p.

Research output: Contribution to journalReview article

78 Scopus citations

Monoclonal antibodies for the prevention and treatment of graft-versus-host disease

Bruner, R. J. & Farag, S. S., Aug 2003, In : Seminars in oncology. 30, 4, p. 509-519 11 p.

Research output: Contribution to journalArticle

25 Scopus citations

New directions in natural killer cell-based immunotherapy of human cancer

Farag, S. S., Fehniger, T. A., Becknell, B., Blaser, B. W. & Caligiuri, M. A., Apr 1 2003, In : Expert Opinion on Biological Therapy. 3, 2, p. 237-250 14 p.

Research output: Contribution to journalReview article

31 Scopus citations

Phase 1 and pharmacodynamic studies of G3139, a Bcl-2 antisense oligonucleotide, in combination with chemotherapy in refractory or relapsed acute leukemia

Marcucci, G., Byrd, J. C., Dai, G., Klisovic, M. I., Kourlas, P. J., Young, D. C., Cataland, S. R., Fisher, D. B., Lucas, D., Chan, K. K., Porcu, P., Lin, Z. P., Farag, S. F., Frankel, S. R., Zwiebel, J. A., Kraut, E. H., Balcerzak, S. P., Bloomfield, C. D., Grever, M. R. & Caligiuri, M. A., Jan 15 2003, In : Blood. 101, 2, p. 425-432 8 p.

Research output: Contribution to journalArticle

188 Scopus citations

Radiation-free regimens result in similar outcomes of allogeneic hematopoietic progenitor cell transplation in patients aged ≥ 50 years compared to young adults with low-risk disease

Farag, S. S., Elder, P. J., Marcucci, G., Penza, S., Mrozek, E., Molina, A., Lin, T., Avalos, B. R. & Copelan, E., Jan 1 2003, In : Bone marrow transplantation. 31, 2, p. 87-93 7 p.

Research output: Contribution to journalReview article

12 Scopus citations
2004

Chronic graft-versus-host disease: Where do we go from here?

Farag, S. S., Mar 1 2004, In : Bone Marrow Transplantation. 33, 6, p. 569-577 9 p.

Research output: Contribution to journalShort survey

44 Scopus citations

Cytokine Modulation of the Innate Immune System in the Treatment of Leukemia and Lymphoma

Farag, S. S. & Caligiuri, M. A., Dec 1 2004, Treatment of Leukemia and Lymphoma. p. 295-318 24 p. (Advances in Pharmacology; vol. 51).

Research output: Chapter in Book/Report/Conference proceedingChapter

23 Scopus citations

FcγRIIIa and FcγRIIa polymorphisms do not predict response to rituximab in B-cell chronic lymphocytic leukemia

Farag, S. S., Flinn, I. W., Modali, R., Lehman, T. A., Young, D. & Byrd, J. C., Feb 15 2004, In : Blood. 103, 4, p. 1472-1474 3 p.

Research output: Contribution to journalArticle

177 Scopus citations

Immunotherapeutic strategies of stem cell transplant in lymphoma.

Farag, S. S., Oct 2004, In : Clinical advances in hematology & oncology : H&O. 2, 10, p. 638-640 3 p.

Research output: Contribution to journalArticle

Prognostic significance of additional cytogenetic abnormalities in newly diagnosed patients with Philadelphia chromosome-positive chronic myelogenous leukemia treated with interferon-alpha: a Cancer and Leukemia Group B study.

Farag, S. S., Ruppert, A. S., Mrózek, K., Carroll, A. J., Pettenati, M. J., Le Beau, M. M., Peterson, B. L., Powell, B. L., Ozer, H., Silver, R. T., Larson, R. A. & Bloomfield, C. D., Jul 2004, In : International journal of oncology. 25, 1, p. 143-151 9 p.

Research output: Contribution to journalArticle

19 Scopus citations

Therapy-related myelodysplasia and leukemia occur infrequently following VP-16 priming and autotransplantation without total body irradiation

Copelan, E., Hoshaw-Woodard, S., Elder, P., Penza, S., Farag, S., Marcucci, G., Lin, T., Ezzone, S., Scholl, M. D., Bechtel, T., Lemeshow, S. & Avalos, B., Jul 1 2004, In : Bone Marrow Transplantation. 34, 1, p. 85-87 3 p.

Research output: Contribution to journalArticle

9 Scopus citations
2005

DC therapy? Let the natural killer answer

Farag, S. S., Sep 15 2005, In : Blood. 106, 6, 1 p.

Research output: Contribution to journalReview article

1 Scopus citations

Diffuse alveolar hemorrhage following gemtuzumab ozogamicin [2]

Lin, T. S., Penza, S. L., Avalos, B. R., Lucarelli, M. R., Farag, S. S., Byrd, J. C. & Copelan, E. A., Apr 1 2005, In : Bone Marrow Transplantation. 35, 8, p. 823-824 2 p.

Research output: Contribution to journalLetter

9 Scopus citations

FCGR3A and FCGR2A polymorphisms may not correlate with response to alemtuzumab in chronic lymphocytic leukemia

Lin, T. S., Flinn, I. W., Modali, R., Lehman, T. A., Webb, J., Waymer, S., Moran, M. E., Lucas, M. S., Farag, S. S. & Byrd, J. C., Jan 1 2005, In : Blood. 105, 1, p. 289-291 3 p.

Research output: Contribution to journalArticle

66 Scopus citations

Generation of alloreactive T-cells in-vitro for cellular therapy

Shao, M., Farag, S. & Chalmers, J., 2005, AIChE Annual Meeting, Conference Proceedings. p. 8690 1 p.

Research output: Chapter in Book/Report/Conference proceedingConference contribution

High-dose busulfan, cyclophosphamide, and etoposide does not improve outcome of allogeneic stem cell transplantation compared to BuCy2 in patients with acute myeloid leukemia

Farag, S. S., Bolwell, B. J., Elder, P. J., Kalaycio, M., Lin, T., Pohlman, B., Penza, S., Marcucci, G., Blum, W., Sobecks, R., Avalos, B. R., Byrd, J. C. & Copelan, E., Apr 1 2005, In : Bone Marrow Transplantation. 35, 7, p. 653-661 9 p.

Research output: Contribution to journalArticle

16 Scopus citations

Outcome of induction and postremission therapy in younger adults with acute myeloid leukemia with normal karyotype: A cancer and leukemia group B study

Farag, S. S., Ruppert, A. S., Mrózek, K., Mayer, R. J., Stone, R. M., Carroll, A. J., Powell, B. L., Moore, J. O., Pettenati, M. J., Koduru, P. R. K., Stamberg, J., Baer, M. R., Block, A. W., Vardiman, J. W., Kolitz, J. E., Schiffer, C. A., Larson, R. A. & Bloomfield, C. D., 2005, In : Journal of Clinical Oncology. 23, 3, p. 482-493 12 p.

Research output: Contribution to journalArticle

111 Scopus citations

Phase II study of topotecan and cyclophosphamide in patients with relapsed and refractory multiple myeloma

Kraut, E. H., Young, D., Farag, S., James, A. G. & Solove, R. J., Oct 1 2005, In : Leukemia Research. 29, 10, p. 1233-1234 2 p.

Research output: Contribution to journalLetter

3 Scopus citations

The scale-up of T cell depletion for mismatched bone marrow transplants

Xiong, Y., Tong, X., Farag, S. & Chalmers, J., 2005, AIChE Annual Meeting, Conference Proceedings. p. 9145 1 p.

Research output: Chapter in Book/Report/Conference proceedingConference contribution

2006

Comparison of two immunomagnetic separation technologies to deplete T cells from human blood samples

Lara, O., Tong, X., Zborowski, M., Farag, S. S. & Chalmers, J. J., May 5 2006, In : Biotechnology and Bioengineering. 94, 1, p. 66-80 15 p.

Research output: Contribution to journalArticle

27 Scopus citations

High disease burden is associated with poor outcomes for patients with acute myeloid leukemia not in remission who undergo unrelated donor cell transplantation

Blum, W., Bolwell, B. J., Phillips, G., Farag, S. S., Lin, T. S., Avalos, B. R., Penza, S. L., Marcucci, G., Byrd, J. C., Kalaycio, M. E., Sobecks, R. M., Pohlman, B., Brown, S., Elder, P. J. & Copelan, E. A., Jan 1 2006, In : Biology of Blood and Marrow Transplantation. 12, 1, p. 61-67 7 p.

Research output: Contribution to journalArticle

15 Scopus citations

Human natural killer cell development and biology

Farag, S. S. & Caligiuri, M. A., May 1 2006, In : Blood Reviews. 20, 3, p. 123-137 15 p.

Research output: Contribution to journalArticle

321 Scopus citations

Immunologic Approaches to Acute Leukemia in the Elderly

Farag, S. S. & Caligiuri, M. A., Apr 1 2006, In : Seminars in Hematology. 43, 2, p. 118-125 8 p.

Research output: Contribution to journalArticle

10 Scopus citations

Long-term Outcome of Hodgkin Disease Patients Following High-Dose Busulfan, Etoposide, Cyclophosphamide, and Autologous Stem Cell Transplantation

Wadehra, N., Farag, S., Bolwell, B., Elder, P., Penza, S., Kalaycio, M., Avalos, B., Pohlman, B., Marcucci, G., Sobecks, R., Lin, T., Andrèsen, S. & Copelan, E., Dec 1 2006, In : Biology of Blood and Marrow Transplantation. 12, 12, p. 1343-1349 7 p.

Research output: Contribution to journalArticle

33 Scopus citations

Pretreatment cytogenetics add to other prognostic factors predicting complete remission and long-term outcome in patients 60 years of age or older with acute myeloid leukemia: Results from Cancer and Leukemia Group B 8461

Farag, S. S., Archer, K. J., Mrózek, K., Ruppert, A. S., Carroll, A. J., Vardiman, J. W., Pettenati, M. J., Baer, M. R., Qumsiyeh, M. B., Koduru, P. R., Ning, Y., Mayer, R. J., Stone, R. M., Larson, R. A. & Bloomfield, C. D., Jul 1 2006, In : Blood. 108, 1, p. 63-73 11 p.

Research output: Contribution to journalArticle

241 Scopus citations

The Effect of KIR Ligand Incompatibility on the Outcome of Unrelated Donor Transplantation: A Report from the Center for International Blood and Marrow Transplant Research, the European Blood and Marrow Transplant Registry, and the Dutch Registry

Farag, S. S., Bacigalupo, A., Eapen, M., Hurley, C., Dupont, B., Caligiuri, M. A., Boudreau, C., Nelson, G., Oudshoorn, M., van Rood, J., Velardi, A., Maiers, M., Setterholm, M., Confer, D., Posch, P. E., Anasetti, C., Kamani, N., Miller, J. S., Weisdorf, D. & Davies, S. M., Aug 1 2006, In : Biology of Blood and Marrow Transplantation. 12, 8, p. 876-884 9 p.

Research output: Contribution to journalArticle

187 Scopus citations
2007

A novel high throughput immunomagnetic cell sorting system for potential clinical scale depletion of T cells for allogeneic stem cell transplantation

Tong, X., Xiong, Y., Zborowski, M., Farag, S. S. & Chalmers, J. J., Oct 2007, In : Experimental Hematology. 35, 10, p. 1613-1622 10 p.

Research output: Contribution to journalArticle

22 Scopus citations

Blood progenitor cell separation from clinical leukapheresis product by magnetic nanoparticle binding and magnetophoresis

Jing, Y., Moore, L. R., Williams, P. S., Chalmers, J. J., Farag, S. S., Bolwell, B. & Zborowski, M., Apr 15 2007, In : Biotechnology and Bioengineering. 96, 6, p. 1139-1154 16 p.

Research output: Contribution to journalArticle

88 Scopus citations

High-dose melphalan versus busulfan, cyclophosphamide, and etoposide as preparative regimens for autologous stem cell transplantation in patients with multiple myeloma

Benson, D. M., Elder, P. J., Lin, T. S., Blum, W., Penza, S., Avalos, B., Copelan, E. & Farag, S. S., Aug 2007, In : Leukemia Research. 31, 8, p. 1069-1075 7 p.

Research output: Contribution to journalArticle

22 Scopus citations

Missing KIR ligands are associated with less relapse and increased graft-versus-host disease (GVHD) following unrelated donor allogeneic HCT

Miller, J. S., Cooley, S., Parham, P., Farag, S. S., Verneris, M. R., McQueen, K. L., Guethlein, L. A., Trachtenberg, E. A., Haagenson, M., Horowitz, M. M., Klein, J. P. & Weisdorf, D. J., Jun 1 2007, In : Blood. 109, 11, p. 5058-5061 4 p.

Research output: Contribution to journalArticle

217 Scopus citations

Multiple myeloma: Clinical practice guidelines in oncology™

Anderson, K. C., Alsina, M., Bensinger, W., Biermann, J. S., Chanan-Khan, A., Comenzo, R. L., De Castro, C. M., Djulbegovic, B., Farag, S., Huff, C. A., Meredith, R., Schriber, J., Shrieve, D., Singhal, S., Smith, M. R., Stockerl-Goldstein, K., Vose, J. M., Weber, D., Yahalom, J. & Yunus, F., Feb 1 2007, In : JNCCN Journal of the National Comprehensive Cancer Network. 5, 2, p. 118-147 30 p.

Research output: Contribution to journalArticle

32 Scopus citations

Negative selection of hematopoietic progenitor cells by continuous magnetophoresis

Jing, Y., Moore, L. R., Schneider, T., Williams, P. S., Chalmers, J. J., Farag, S. S., Bolwell, B. & Zborowski, M., Apr 1 2007, In : Experimental Hematology. 35, 4, p. 662-672 11 p.

Research output: Contribution to journalArticle

21 Scopus citations

OSU-03012, a novel celecoxib derivative, is cytotoxic to myeloma cells and acts through multiple mechanisms

Zhang, S., Suvannasankha, A., Crean, C. D., White, V. L., Johnson, A., Chen, C. S. & Farag, S. S., Aug 15 2007, In : Clinical Cancer Research. 13, 16, p. 4750-4758 9 p.

Research output: Contribution to journalArticle

45 Scopus citations
2008

Addition of Infliximab to Standard Acute Graft-versus-Host Disease Prophylaxis following Allogeneic Peripheral Blood Cell Transplantation

Hamadani, M., Hofmeister, C. C., Jansak, B., Phillips, G., Elder, P., Blum, W., Penza, S., Lin, T. S., Klisovic, R., Marcucci, G., Farag, S. S. & Devine, S. M., Jul 1 2008, In : Biology of Blood and Marrow Transplantation. 14, 7, p. 783-789 7 p.

Research output: Contribution to journalArticle

41 Scopus citations

Antimyeloma effects of a sesquiterpene lactone parthenolide

Suvannasankha, A., Crean, C. D., Shanmugam, R., Farag, S. S., Abonour, R., Boswell, H. S. & Nakshatri, H., Mar 15 2008, In : Clinical Cancer Research. 14, 6, p. 1814-1822 9 p.

Research output: Contribution to journalArticle

32 Scopus citations